YESHWANT KRISHNA sold 1.9% of their position (85.66K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.25M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−53.70K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−23.73K
Price / share
$37.91
Trade value
$899.59K
% of position
Common Stock
Shares
−23.27K
Price / share
$38.94
Trade value
$906.40K
% of position
Common Stock
Shares
−6.60K
Price / share
$40.16
Trade value
$265.08K
% of position
Common Stock
Shares
−88.00
Price / share
$40.64
Trade value
$3.58K
% of position
Common Stock
Shares
−31.96K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−29.33K
Price / share
$36.69
Trade value
$1.08M
% of position
Common Stock
Shares
−2.38K
Price / share
$37.82
Trade value
$89.90K
% of position
Common Stock
Shares
−260.00
Price / share
$38.64
Trade value
$10.05K
% of position
Net shares
−171.32K
Net value
-$3.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/31/2022 | J · J | −53.70K | — | — | 0.8% | 6.32M | 6.27M |
| Common Stock Indirect | 10/31/2022 | S · Sale | −23.73K | $37.91 | $899.59K | 0.5% | 4.47M | 4.45M |
| Common Stock Indirect | 10/31/2022 | S · Sale | −23.27K | $38.94 | $906.40K | 0.5% | 4.45M | 4.43M |
| Common Stock Indirect | 10/31/2022 | S · Sale | −6.60K | $40.16 | $265.08K | 0.1% | 4.43M | 4.42M |
| Common Stock Indirect | 10/31/2022 | S · Sale | −88.00 | $40.64 | $3.58K | 0.0% | 4.42M | 4.42M |
| Common Stock Indirect | 11/1/2022 | J · J | −31.96K | — | — | 0.5% | 6.27M | 6.24M |
| Common Stock Indirect | 11/1/2022 | S · Sale | −29.33K | $36.69 | $1.08M | 0.7% | 4.42M | 4.39M |
| Common Stock Indirect | 11/1/2022 | S · Sale | −2.38K | $37.82 | $89.90K | 0.1% | 4.39M | 4.39M |
| Common Stock Indirect | 11/1/2022 | S · Sale | −260.00 | $38.64 | $10.05K | 0.0% | 4.39M | 4.39M |
| Total | −171.32K | -$3.25M | ||||||